Bioventus Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
| Przychód (średnia) |
564.94 |
565.41 |
600.73 |
635.90 |
| Przychód Δ r/r |
0.00% |
0.08% |
6.25% |
5.86% |
| Przychód (min) |
563.23 |
563.70 |
596.00 |
633.98 |
| Przychód (max) |
566.11 |
566.58 |
603.70 |
637.22 |
| EBITDA (średnia) |
-11.44 |
-11.45 |
-12.17 |
-12.88 |
| EBIT (średnia) |
-66.30 |
-66.36 |
-70.50 |
-74.63 |
| EBIT % |
-11.74% |
-11.74% |
-11.74% |
-11.74% |
| Zysk netto (średni) |
26.26 |
37.53 |
49.32 |
51.27 |
| Zysk netto % |
4.65% |
6.64% |
8.21% |
8.06% |
| EPS (średnia) |
0.40 |
0.57 |
0.77 |
0.79 |
| Liczba analityków (Przychody) |
2 |
2 |
4 |
2 |
| Liczba analityków (EPS) |
2 |
2 |
3 |
1 |
| symbol |
BVS |
BVS |
BVS |
BVS |